The influence of high versus low sodium intake on blood pressure and haemodynamics in patients with morbid obesity

Journal of Hypertension

Volumn 31, Issue 11, 2013, Pages 2220-2229

  Bonfils, Peter K ^a   Taskiran, Mustafa ^a   Damgaard, Morten ^a   Goetze, Jens P ^b   Floyd, Andrea K ^a   Funch Jensen, Peter ^c   Kristiansen, Viggo B ^a   Gadsbøll, Niels ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

hypertension; obesity; salt sensitivity; sodium

Indexed keywords

SODIUM INTAKE;

ADMINISTRATION AND DOSAGE; BLOOD PRESSURE; COMPLICATION; EXERCISE; FEMALE; HEART OUTPUT; HEMODYNAMICS; HUMAN; HYPERTENSION; MALE; MORBID OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REST; SODIUM INTAKE; SODIUM RESTRICTION; VASCULAR RESISTANCE;

BLOOD PRESSURE; CARDIAC OUTPUT; DIET, SODIUM-RESTRICTED; EXERCISE; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION; MALE; OBESITY, MORBID; REST; SODIUM, DIETARY; VASCULAR RESISTANCE;

EID: 84885613851     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328363c769     Document Type: Article

References (54)

1. Jordan J, Yumuk V, Schlaich M, Nilsson PM, Zahorska-Markiewicz B, Grassi G, et al. Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. J Hypertens 2012; 30:1047-1055.
2. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162:1867-1872.
3. Corry DB, Tuck ML. Obesity, hypertension, and sympathetic nervous system activity. Curr Hypertens Rep 1999; 1:119-126.
4. Grassi G, Cattaneo BM, Seravalle G, Colombo M, Cavagnini F, Mancia G. Obesity and the sympathetic nervous system. Blood Press Suppl 1996; 1:43-46.
5. Galletti F, Strazzullo P. Involvement of the renin-angiotensin system in obesity: older and newer pathways. Nutr Metab Cardiovasc Dis 2007; 17:699-704.
6. Rocchini AP. Obesity hypertension, salt sensitivity and insulin resistance. Nutr Metab Cardiovasc Dis 2000; 10:287-294.
7. Hall JE. Mechanisms of abnormal renal sodium handling in obesity hypertension. Am J Hypertens 1997; 10:49S-55S.
8. Thakur V, Richards R, Reisin E. Obesity, hypertension, and the heart. Am J Med Sci 2001; 321:242-248.
9. Elliott P, Stamler J, Nichols R, Dyer AR, Stamler R, Kesteloot H, Marmot M. Intersalt revisited: further analyses of 24 h sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. BMJ 1996; 312:1249-1253.
10. He FJ, MacGregor GA. Salt, blood pressure and cardiovascular disease. Curr Opin Cardiol 2007; 22:298-305.
11. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASHSodium Collaborative Research Group. N Engl J Med 2001; 344: 3-10.
12. Dimsdale JE, Ziegler M, Mills P, Berry C. Prediction of salt sensitivity. Am J Hypertens 1990; 3:429-435.
13. Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). Am J Hypertens 2012; 25:1-15.
14. Luft FC, Weinberger MH. Heterogeneous responses to changes in dietary salt intake: the salt-sensitivity paradigm. Am J Clin Nutr 1997; 65:612S-617S.
15. Midgley JP, Matthew AG, Greenwood CM, Logan AG. Effect of reduced dietary sodium on blood pressure: A meta-analysis of randomized controlled trials. JAMA 1996; 275:1590-1597.
16. Gerdts E, Lund-Johansen P, Omvik P. Reproducibility of salt sensitivity testing using a dietary approach in essential hypertension. J Hum Hypertens 1999; 13:375-384.
17. Kawasaki T, Delea CS, Bartter FC, Smith H. The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med 1978; 64:193-198.
18. Weinberger MH. Sodium sensitivity of blood pressure. Curr Opin Nephrol Hypertens 1993; 2:935-939.
19. Krzesinski JM, Cohen EP. Hypertension and the kidney. Acta Clin Belg 2007; 62:5-14.
20. Rodriguez-Iturbe B, Romero F, Johnson RJ. Pathophysiological mechanisms of salt-dependent hypertension. Am J Kidney Dis 2007; 50:655-672.
21. Chen J, Gu D, Huang J, Rao DC, Jaquish CE, Hixson JE, et al. Metabolic syndrome and salt sensitivity of blood pressure in nondiabetic people in China: A dietary intervention study. Lancet 2009; 373:829-835.
22. Hoffmann IS, Cubeddu LX. Increased blood pressure reactivity to dietary salt in patients with the metabolic syndrome. J Hum Hypertens 2007; 21:438-444.
23. Strazzullo P, Barbato A, Galletti F, Barba G, Siani A, Iacone R, et al. Abnormalities of renal sodium handling in the metabolic syndrome. Results of the Olivetti Heart Study. J Hypertens 2006; 24:1633-1639.
24. Uzu T, Kimura G, Yamauchi A, Kanasaki M, Isshiki K, Araki S, et al. Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension. J Hypertens 2006; 24:1627-1632.
25. Logan AG. Dietary sodium intake and its relation to human health: A summary of the evidence. J Am Coll Nutr 2006; 25:5.
26. Bonfils PK, Damgaard M, Stokholm KH, Nielsen SL. 99mTc-albumin can replace 125I-albumin to determine plasma volume repeatedly. Scand J Clin Lab Invest 2012; 72:447-451.
27. Brochner-Mortensen J. A simple single injection method for determination of the extracellular fluid volume. Scand J Clin Lab Invest 1980; 40:567-573.
28. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440-1463.
29. Gabrielsen A, Videbaek R, Schou M, Damgaard M, Kastrup J, Norsk P. Noninvasive measurement of cardiac output in heart failure patients using a new foreign gas rebreathing technique. Clin Sci (Lond) 2002; 102:247-252.
30. Overlack A, Ruppert M, Kolloch R, Gobel B, Kraft K, Diehl J, et al. Divergent hemodynamic and hormonal responses to varying salt intake in normotensive subjects. Hypertension 1993; 22:331-338.
31. Alehagen U, Dahlstrom U, Rehfeld JF, Goetze JP. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure. JAMA 2011; 305:2088-2095.
32. Hunter I, Alehagen U, Dahlstrom U, Rehfeld JF, Crimmins DL, Goetze JP. N-Terminal pro-atrial natriuretic peptide measurement in plasma suggests covalent modification. Clin Chem 2011; 57:1327-1330.
33. Damgaard M, Norsk P, Gustafsson F, Kanters JK, Christensen NJ, Bie P, et al. Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure. Am J Physiol Regul Integr Comp Physiol 2006; 290:R1294-R1301.
34. Wright JT, Rahman M, Scarpa A, Fatholahi M, Griffin V, Jean-Baptiste R, et al. Determinants of salt sensitivity in black and white normotensive and hypertensive women. Hypertension 2003; 42:1087-1092.
35. Fujiwara N, Osanai T, Kamada T, Katoh T, Takahashi K, Okumura K. Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension: modulation of nitric oxide synthesis by salt intake. Circulation 2000; 101:856-861.
36. Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell'Italia LJ, et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 2009; 54:475-481.
37. Cogswell ME, Zhang Z, Carriquiry AL, Gunn JP, Kuklina EV, Saydah SH, et al. Sodium and potassium intakes among US adults: NHANES 2003-2008. Am J Clin Nutr 2012; 96:647-657.
38. Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, Katch V, et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 1989; 321:580-585.
39. Egan BM, Stepniakowski K, Goodfriend TL. Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering. Am J Hypertens 1994; 7:886-893.
40. Egan BM, Stepniakowski KT. Adverse effects of short-term, very-lowsalt diets in subjects with risk-factor clustering. Am J Clin Nutr 1997; 65:671S-677S.
41. Arone LJ, Mackintosh R, Rosenbaum M, Leibel RL, Hirsch J. Autonomic nervous system activity in weight gain and weight loss. Am J Physiol 1995; 269:R222-R225.
42. Abrahaõ SB, Tinucci T, Santello JL, Mion D Jr. Salt suppresses baseline muscle sympathetic nerve activity in salt-sensitive and salt-resistant hypertensives. J Hum Hypertens 2002; 16:843-850.
43. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension 1989; 14:177-183.
44. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Bolla G, Mancia G. Baroreflex impairment by low sodium diet in mild or moderate essential hypertension. Hypertension 1997; 29:802-807.
45. Grassi G, Dell'Oro R, Seravalle G, Foglia G, Trevano FQ, Mancia G. Short-and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension. Circulation 2002; 106:1957-1961.
46. Frohlich ED, Susic D. Sodium and its multiorgan targets. Circulation 2011; 124:1882-1885.
47. He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 2009; 23:363-384.
48. Messerli FH, Schmieder RE, Weir MR. Salt. A perpetrator of hypertensive target organ disease? Arch Intern Med 1997; 157:2449-2452.
49. Susic D, Frohlich ED. Salt consumption and cardiovascular, renal, and hypertensive diseases: Clinical and mechanistic aspects. Curr Opin Lipidol 2012; 23:11-16.
50. Gupta BN, Linden RJ, Mary DA, Weatherill D. The influence of high and low sodium intake on blood volume in the dog. Q J Exp Physiol 1981; 66:117-128.
51. el-Sayed H, Hainsworth R. Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart 1996; 75:134-140.
52. Folkow B, Ely D. Importance of the blood pressure-heart rate relationship. Blood Press 1998; 7:133-138.
53. Fang Z, Sripairojthikoon W, Calhoun DA, Zhu S, Berecek KH, Wyss JM. Interaction between lifetime captopril treatment and NaCI-sensitive hypertension in spontaneously hypertensive rats and Wistar-Kyoto rats. J Hypertens 1999; 17:983-991.
54. Wyss JM, Roysommuti S, King K, Kadisha I, Regan CP, Berecek KH. Salt-induced hypertension in normotensive spontaneously hypertensive rats. Hypertension 1994; 23:791-796.